Skip to main content

Trevena's opioid painkiller fails to get FDA panel nod

An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approval of Trevena Inc's opioid injection for managing acute pain.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.